Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Arch Biopartners Inc V.ARCH

Alternate Symbol(s):  ACHFF

Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is LSALT Peptide. The Company is engaged in the clinical development of LSALT Peptide and other DPEP-1 targeting drug candidates for indications where inflammation of the lungs, liver and kidneys is an unmet problem. LSALT Peptide is in a second phase II trial, targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI). The Company has additional technology platforms in its portfolio, which are AB569 and Borg. AB569 is an anti-infective candidate for treating or preventing antibiotic resistant bacterial infections, primarily as a topical treatment for wounds.


TSXV:ARCH - Post by User

Post by C10H12N2on Dec 30, 2021 9:25pm
172 Views
Post# 34272796

Just Remember River. It was YOU who randomly attacked AGN.

Just Remember River. It was YOU who randomly attacked AGN.You attacked a company not even competing with arch. Are you in the DMT/Stroke psychedelic space? Are you in the Chronic Cough space? Are you in the Small Cell Lung Cancer space? Are you in the Idiopathic Pulmonary Fibrosis space? Are you in the Nonalcoholic Fatty Liver Disease space? Are you in the Chronic Kidney Disease space? Are you in the Irritable Bowel Disease space? I'm just trying to understand how Algernon is a threat to the wellbeing or outcome of anything arch is pursuing? Now we have one of your attack dogs off the leash again with more asinine stuff that nobody is going to waste their time debunking yet AGAIN. What you've done says more about one's character than it does about your knowledge of anything you trade or trash. Carry on...
<< Previous
Bullboard Posts
Next >>